GT200500122A - Profarmacos de esteroides con accion androgenica - Google Patents

Profarmacos de esteroides con accion androgenica

Info

Publication number
GT200500122A
GT200500122A GT200500122A GT200500122A GT200500122A GT 200500122 A GT200500122 A GT 200500122A GT 200500122 A GT200500122 A GT 200500122A GT 200500122 A GT200500122 A GT 200500122A GT 200500122 A GT200500122 A GT 200500122A
Authority
GT
Guatemala
Prior art keywords
propharms
steroid
androgenic action
androgenic
action
Prior art date
Application number
GT200500122A
Other languages
English (en)
Inventor
Peter Droescher
Walter Elger
Alexander Hillisch
Gudrun Reddersen
Sven Ring
Birgitt Schneider
Ralf Wyrwa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200500122A publication Critical patent/GT200500122A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A PRODROGAS DE ESTRIOL Y ESTETROL DE FORMULA GENERAL I EN DONDE R1,R2,R3,X,X1,N, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. LA SOLICITUD ADEMAS PRESENTA PROCEDIMIENTOS PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE CONTIENEN EL COMPUESTO Y CON SU USO PARA PREPARAR MEDICAMENTOS CON EFECTO ESTROGENICO.
GT200500122A 2004-05-21 2005-05-20 Profarmacos de esteroides con accion androgenica GT200500122A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004025986A DE102004025986A1 (de) 2004-05-21 2004-05-21 Steroid-Prodrugs mit androgener Wirkung

Publications (1)

Publication Number Publication Date
GT200500122A true GT200500122A (es) 2006-01-24

Family

ID=34968657

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200500122A GT200500122A (es) 2004-05-21 2005-05-20 Profarmacos de esteroides con accion androgenica

Country Status (22)

Country Link
EP (1) EP1747229A1 (es)
JP (1) JP2007538026A (es)
CN (1) CN1993375A (es)
AR (1) AR049547A1 (es)
AU (1) AU2005245568A1 (es)
BR (1) BRPI0510136A (es)
CA (1) CA2564963A1 (es)
CR (1) CR8785A (es)
DE (1) DE102004025986A1 (es)
EA (1) EA200602049A1 (es)
EC (1) ECSP067028A (es)
GT (1) GT200500122A (es)
IL (1) IL179293A0 (es)
MX (1) MXPA06013469A (es)
NO (1) NO20065885L (es)
PA (1) PA8633601A1 (es)
PE (1) PE20060271A1 (es)
SV (1) SV2006002123A (es)
TW (1) TW200613317A (es)
UY (1) UY28911A1 (es)
WO (1) WO2005113575A1 (es)
ZA (1) ZA200610769B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (de) 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
DE102005057224A1 (de) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE102005057408A1 (de) * 2005-11-30 2007-05-31 Bayer Schering Pharma Ag Sulfamoylsulfonat-Prodrugs
CN101708338B (zh) * 2008-12-26 2014-06-04 中国人民解放军军事医学科学院放射与辐射医学研究所 含甾体结构的前药及其高度分散制剂
CN102964417A (zh) * 2012-11-30 2013-03-13 华中药业股份有限公司 17-羟基四氢吡喃醚甾族化合物的合成方法
CN107556258B (zh) * 2017-08-22 2021-06-04 湖北江田精密化学有限公司 一种4-氨基-2-氯-5(1h-四唑基-5)苯磺酰胺的制备方法
EP3533619A1 (en) 2018-03-02 2019-09-04 Basf Se Heat sensitive recording material and color developer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH545316A (de) * 1970-07-17 1973-12-15 Hoffmann La Roche Verfahren zur Herstellung von Acylderivaten
US5001234A (en) * 1987-04-16 1991-03-19 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
DE19712488A1 (de) * 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
DE10027887A1 (de) * 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
TW200613317A (en) 2006-05-01
AR049547A1 (es) 2006-08-16
EP1747229A1 (de) 2007-01-31
MXPA06013469A (es) 2007-01-23
AU2005245568A1 (en) 2005-12-01
PA8633601A1 (es) 2006-07-03
CA2564963A1 (en) 2005-12-01
CR8785A (es) 2007-02-05
DE102004025986A1 (de) 2005-12-15
IL179293A0 (en) 2007-03-08
ECSP067028A (es) 2006-12-29
JP2007538026A (ja) 2007-12-27
SV2006002123A (es) 2006-02-15
UY28911A1 (es) 2005-12-30
ZA200610769B (en) 2008-08-27
EA200602049A1 (ru) 2007-06-29
NO20065885L (no) 2006-12-19
WO2005113575A1 (de) 2005-12-01
CN1993375A (zh) 2007-07-04
PE20060271A1 (es) 2006-05-25
BRPI0510136A (pt) 2007-10-02

Similar Documents

Publication Publication Date Title
GT200500122A (es) Profarmacos de esteroides con accion androgenica
GT200500120A (es) Prodrogas de estriol y estetrol
RS51569B (en) COMPOSITIONS CONTAINING CRYSTAL TRANS - (+/-) - DELTA-9-TETRAHYDROCANABINOL
CU20060153A7 (es) Nueva forma cristalina v de agomelatina, procedimiento para su preparación y composiciones farmacéuticas que las contienen
PA8854101A1 (es) Derivados de imidazol bicíclicos sustituidos como moduladores de gamma secretasa
CL2009000541A1 (es) Uso de una enzima degradadora de matriz activable (amde) para la formulacion de un medicamento de administracion sub-epidermica; composicion farmacologica y su uso; combinacion que comprende a amde, un activador y un agente; recipiente para amde y para el activador; kit que comprende dicho recipiente
ES2721148T3 (es) Composiciones farmacéuticas de paclitaxel, análogos de paclitaxel o conjugados de paclitaxel y métodos relacionados de preparación y uso
BRPI0418330A (pt) composições sólidas de drogas de solubilidade baixa e poloxámeros
BRPI0519242A2 (pt) uso derivados de 1-aminociclohexano para o tratamento de esclerose méltipla, instabilidade emocional e paralisia pseudobulbar
BRPI0620229A8 (pt) formulação
CY1107906T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει παραγωγα οιστετρολης για χρηση στην θεραπεια κατα του καρκινου
MEP14508A (en) Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels
EA201000436A1 (ru) Стероидные [3,2-с]пиразольные соединения, обладающие глюкокортикоидной активностью
UY30215A1 (es) Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones
UY29236A1 (es) 2-alcoxi-3,4,5-trihidroxi-alquilamidas. su preparación, composiciones que las contienen y su utilización.
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
CO6420349A2 (es) Novedoso derivados de compuestos esteroidal[3,2-c]pirazoles con actividad glucocorticoide
UY28909A1 (es) Prodrogas de estradiol
BRPI0418070A (pt) composição para cuidados pessoais, uso de uma uréia substituìda e método para reduzir a degradação da cor de uma composição para cuidados pessoais
RS51282B (sr) Kompozicije sa pojačanim delovanjem na poboljšanje elastičnosti
ECSP088899A (es) Derivados de 2-alcoxi-3,4,5-trihidroxi-alquilamida, su preparación, composiciones que las contienen y utilización
ECSP088893A (es) 2-alcoxi-3, 4,5-trihidroxi-alquilamida-benzazepinas, su preparación, composiciones que las contienen y utilización
ATE301469T1 (de) Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase
PA8629401A1 (es) D-homo-17-cloro-16 (17) eno esteroides
ECSP088897A (es) 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzotiazepinas, su preparación, composiciones que las contienen y utilización